Atea Pharmaceuticals (AVIR)
(Delayed Data from NSDQ)
$3.67 USD
-0.15 (-3.93%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.68 +0.01 (0.27%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.50 | 0.00% |
Earnings Summary
For their last quarter, Atea Pharmaceuticals (AVIR) reported earnings of -$0.48 per share, beating the Zacks Consensus Estimate of $-0.77 per share. This reflects a positive earnings surprise of 37.66%. Look out for AVIR's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.50 per share, reflecting a year-over-year decrease of 25%.
Earnings History
Price & Consensus
Zacks News for AVIR
All You Need to Know About Atea Pharmaceuticals (AVIR) Rating Upgrade to Buy
AVIR: What are Zacks experts saying now?
Zacks Private Portfolio Services